Anti-PJA1 antibody (1-240 aa) (STJ11105962)

SKU:
STJ11105962

Current Stock:
Host: Rabbit
Applications: WB/ELISA
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.02% Sodium Azide, 50% Glycerol, pH 7.3.
Purification: Affinity purification
Concentration: Lot specific
Dilution Range: WB:1:500-1:2000
ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements.
Gene Symbol: PJA1
Gene ID: 64219
Uniprot ID: PJA1_HUMAN
Immunogen Region: 1-240 aa
Specificity: Recombinant fusion protein containing a sequence corresponding to amino acids 1-240 of human PJA1 (NP_660095.1).
Immunogen Sequence: MGQESSKPVWPNPTGGYQSN TGRRYGRRHAYVSFRPPTSQ RERIASQRKTNSEVPMHRSA PSQTTKRSRSPFSTTRRSWD DSESSGTNLNIDNEDYSRYP PREYRASGSRRGMAYGHIDS YGADDSEEEGAGPVERPPVR GKTGKFKDDKLYDPEKGARS LAGPPPHFSSFSRDVREERD KLDPVPAARCSASRADFLPQ SSVASQSSSEGKLATKGDSS ERERREQNLPARPSRAPVS
Tissue Specificity Expressed in various regions of the brain including the cerebellum, cerebral cortex, medulla, occipital pole, frontal lobe, temporal lobe and putamen. Highest levels in the cerebral cortex.
Post Translational Modifications Substrate for E2-dependent ubiquitination.
Function Has E2-dependent E3 ubiquitin-protein ligase activity. Ubiquitinates MAGED1 antigen leading to its subsequent degradation by proteasome. May be involved in protein sorting.
Protein Name E3 Ubiquitin-Protein Ligase Praja-1
Praja1
Ring Finger Protein 70
Ring-Type E3 Ubiquitin Transferase Praja-1
Database Links Reactome: R-HSA-983168
Alternative Antibody Names Anti-E3 Ubiquitin-Protein Ligase Praja-1 antibody
Anti-Praja1 antibody
Anti-Ring Finger Protein 70 antibody
Anti-Ring-Type E3 Ubiquitin Transferase Praja-1 antibody
Anti-PJA1 antibody
Anti-RNF70 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance